Search Results - "Thanigaikumar, Murugaiyan"

Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari Syndrome by Patel, Raj K., Lea, Nicholas C., Heneghan, Michael A., Westwood, Nigel B., Milojkovic, Dragana, Thanigaikumar, Murugaiyan, Yallop, Deborah, Arya, Roopen, Pagliuca, Antonio, Gäken, Joop, Wendon, Julia, Heaton, Nigel D., Mufti, Ghulam J.

“…Background & Aims: Budd–Chiari Syndrome (BCS) results from obstruction to hepatic venous outflow, with myeloproliferative disorder (MPD) accounting for up to…”
Get full text

A Large London District General Hospital Highlights CLL and Bame As Risk Factors for Severe Disease Amongst Haematology-Oncology Patients by Farmer, Isabel, Babiker, Samah, Okikiolu, Jumoke Stella, Steel, Matthew, Wanniarachchi, Chandima, Littlewood, Shona, Tan, Yishi, Imaeva, Kameta, Duran, Ana, Douvali, Evdoxia, Thanigaikumar, Murugaiyan, Gupta, Sunil, Yeghen, Tullie, Rashid, Sabia, Mir, Naheed, Sahu, Satyajit, Oram, Sarah

“…Introduction The earliest documented transmission of the coronavirus SARS-CoV-2, causing the disease Covid-19 occurred in the United Kingdom in February 2020…”
Get full text

Treatment burden, haemostatic strategies and real world inhibitor screening practice in non‐severe haemophilia A by Batty, Paul, Austin, Steve K., Khair, Kate, Millar, Carolyn M., Palmer, Ben, Rangarajan, Savita, Stümpel, Jan‐Phillip, Thanigaikumar, Murugaiyan, Yee, Thynn T., Hart, Daniel P.

“…Summary Inhibitor formation in non‐severe haemophilia A is a life‐long risk and associated with morbidity and mortality. There is a paucity of data to…”
Get full text

Use of Intravenous Busulphan for Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT) Is Associated with Delayed T-Cell Full Donor Chimerism and Lower Incidence of Acute Graft Versus Host Disease by Lim, ZiYi, Thanigaikumar, Murugaiyan, Gandhi, Shreyans, Pearce, Laurence, Kenyon, Michelle, Ho, Aloysius Y.L., Devereux, Stephen, Pagliuca, Antonio, Mufti, Ghulam J.

“…The use of IV busulphan (Bu) has reported improved bioavailability with lower variability of busulphan plasma levels, and may reduce the effects of transplant…”
Get full text